Skandinaviska Enskilda Banken (SEB)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-114,063	Closed	-$1.02M	–	801
2025 Q2	$1.02M	Hold	114,063	–	–	﹤0.01%	646
2025 Q1	$855K	Hold	114,063	–	–	﹤0.01%	655
2024 Q4	$859K	Hold	114,063	–	–	﹤0.01%	670
2024 Q3	$867K	Hold	114,063	–	–	﹤0.01%	683
2024 Q2	$705K	Hold	114,063	–	–	﹤0.01%	663
2024 Q1	$579K	Sell	114,063 -76,478	-40%	-$430K	﹤0.01%	699
2023 Q4	$1.14M	Hold	190,541	–	–	0.01%	680
2023 Q3	$1.35M	Hold	190,541	–	–	0.01%	630
2023 Q2	$1.34M	Buy	190,541 +96,101	+102%	+$771K	0.01%	647
2023 Q1	$788K	Sell	94,440 -4,646	-5%	-$44.7K	0.01%	724
2022 Q4	$1.14M	Sell	99,086 -5,743	-5%	-$71.6K	0.01%	655
2022 Q3	$1.32M	Hold	104,829	–	–	0.01%	619
2022 Q2	$1.11M	Hold	104,829	–	–	0.01%	692
2022 Q1	$1.71M	Hold	104,829	–	–	0.01%	654
2021 Q4	$1.45M	Hold	104,829	–	–	0.01%	719
2021 Q3	$1.51M	Buy	+104,829	New	+$1.65M	0.01%	716